Evaluating the Transition from Targeted to Exome Sequencing: A Guide for Clinical Laboratories.
Ontology highlight
ABSTRACT: The transition from targeted to exome or genome sequencing in clinical contexts requires quality standards, such as targeted sequencing, in order to be fully adopted. However, no clear recommendations or methodology have emerged for evaluating this technological evolution. We developed a structured method based on four run-specific sequencing metrics and seven sample-specific sequencing metrics for evaluating the performance of exome sequencing strategies to replace targeted strategies. The indicators include quality metrics and coverage performance on gene panels and OMIM morbid genes. We applied this general strategy to three different exome kits and compared them with a myopathy-targeted sequencing method. After having achieved 80 million reads, all-tested exome kits generated data suit
SUBMITTER: Yauy K
PROVIDER: S-EPMC10138641 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA